Diagnostics impacted Q3 performance; Q4 core business outlook provides relief
31/07/26 -"Siemens Healthineers’ Q3 sales slightly missed expectations, though profitability met forecasts. The Precision Therapy and Imaging segments reported growth, while Diagnostics underperformed due ..."
Pages
72
Language
English
Published on
31/07/26
You may also be interested by these reports :
05/08/26
Fresenius delivered a strong Q2, with adjusted EBIT and core EPS coming in comfortably ahead of expectations and revenue broadly in line. The beat ...
03/08/26
Our TP has been cut slightly, reflecting an update to the model (net debt, and updated market parameters), with no change to the operational ...
03/08/26
Smart glasses development continues to erode margins. We will take a more conservative view of the company and revise our long-term margin ...
02/08/26
DiaSorin’s Q2 profitability surpassed expectations. Despite weak respiratory sales and challenges in China, revenue grew by mid-single digits. All ...